Disposable Bronchoscope Market Size, Share & Trends Analysis Report By End-use (Hospitals, Outpatient Facilities), By Region (Asia Pacific, North America), And Segment Forecasts, 2023 - 2030

Report Overview

The global disposable bronchoscope market size was estimated at USD 595.1 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 13.8% from 2023 to 2030. Transitioning from traditional open surgeries to minimally invasive procedures for diagnostic and therapeutic purposes is driving the growth of the market. Furthermore, some of the other factors impacting the market growth include the increasing incidence of lung cancer, growing demand for local biopsies, the growing geriatric population coupled with the rising prevalence of chronic respiratory disorders, and technological advancements in the field of bronchoscopy devices.

The increasing prevalence of chronic respiratory disorders, such as lung cancer, tumors airway stenosis, pneumonia, bronchitis, lung infections, and chronic obstructive pulmonary disease (COPD), is driving the demand for bronchoscopies and local biopsies for both therapeutics and diagnostics purposes in viewing abnormalities in the airway, obtain tissue specimens of the lung, and to assess growths in the airway. Healthcare professionals are utilizing disposable bronchoscopes in diagnosing or treating respiratory ailments since they enable minimal intervention and shorten the recovery time. The development of single-use bronchoscopes to avoid the incidence of infections is also one of the key trends expected to drive market growth.

An increase in research initiatives focused on analyzing the efficacy of endoscopic treatments for non-cancerous diseases is also propelling the market growth. Moreover, the increasing global geriatric population is expected to support market growth. As per the Administration on Aging (AoA) in 2019, 16% of the U.S. population was aged 65 years & above and is expected to reach 21.6% by 2040. The growing trend of minimally invasive procedures in assessing the airway and tracheobronchial tree for respiratory tract diseases coupled with new product approvals is driving the market growth.

For instance, in August 2021, Boston Scientific received U.S. FDA clearance for disposable bronchoscopes, eliminating the risk of infection usually associated with reusable bronchoscopes. In addition, the rising preference for minimally invasive procedures is associated with benefits, such as higher patient satisfaction, economic viability, shortened hospitalization, and reduced post-procedural complications. PENTAX Medical, Boston Scientific Corp., AMBU A/S, NeoScope Inc., Olympus, and Fujifilm Holding Corp. are among the key players in the market. Moreover, the prevalence of several respiratory disorders is the key factor bolstering the growth.

As per the World Health Organization (WHO) estimates, 3.3 million individuals annually succumb to COPD. Furthermore, as per the American Cancer Society estimates in 2018, 235, 070 new cases of lung cancer and tumors were detected in the U.S., which augmented the demand for bronchoscopies for biopsies to detect and treat lung cancers. In addition, as per Cancer Research UK, 47,800 new lung cancer cases are diagnosed annually. As per the World Cancer Research Fund International, developing countries account for 58.7% of lung cancer cases. Thus, such an alarming incidence rate is anticipated to drive the demand for bronchoscopies across the globe.

The risk of infection and contamination in using reusable bronchoscopes also presents growth opportunities for disposable bronchoscopes. The COVID-19 pandemic significantly impacted the market and disrupted workflows across the entire healthcare industry. Several bronchoscopy procedures, such as visualization and documentation systems, witnessed a negative impact due to the pandemic. Bronchoscopy procedures involve a high amount of risk owing to the increased pressures used to oxygenate the patient, detectible disruption of respiratory tract mucosa, close contact between a healthcare professional & patient, and generation of significant amounts of droplets & aerosols, which can contaminate procedure room equipment, personnel, and present infection risk.

Although the risks are associated with bronchoscopy procedures, bronchoscopy remains a vital and imperative procedure in diagnosis and treating respiratory diseases and cannot be postponed in certain instances. The pandemic challenged the prioritization of patients requiring prompt bronchoscopies. The changing regulations about surgical procedures and supply chain disruptions challenged the market growth during the pandemic.

End-use Insights

The end-use segment includes hospitals and outpatient facilities. In 2022, the outpatient facilities segment accounted for the highest market share of 53.3% and is anticipated to register the fastest CAGR of 14.5% over the forecast period. This is attributed to the significant adoption & utilization rate of disposable bronchoscopes in outpatient facilities compared to other healthcare facilities. In addition, growing favorable reimbursement policies and advancing healthcare infrastructure in developed & emerging economies are driving the segment growth.

Growing awareness levels about contamination risks and hospital-acquired infections associated with reusable devices are contributing to the growth of this segment. Cost-effectiveness associated with disposable bronchoscopes compared to reusable devices is driving the adoption rate of these devices in outpatient facilities. Shortened procedure time, minimal discomfort, enhanced patient satisfaction, reduced postoperative care, and quicker recovery time are boosting the adoption of these devices in outpatient facilities. The growing trend of same-day surgeries is expected to propel the growth of the clinic segment over the forecast period.

Regional Insights

North America dominated the market with a revenue share of 40.9% in 2022. The high share is attributed to the rapid adoption of advanced technologies, the growing trend of minimally invasive procedures, the growing geriatric population, the rising prevalence of chronic respiratory disorders, and advancing healthcare infrastructure. Furthermore, the presence of several key manufacturers, suppliers, distributors, and regulatory approvals for disposable bronchoscopes is driving the growth.

On the other hand, Asia Pacific is anticipated to register the fastest CAGR of 15.0% over the forecast period owing to the advancing, improving healthcare infrastructure, substantial economic development, presence of lesser regulatory frameworks, growing geriatric population, and rising prevalence of lung cancers & COPD. Moreover, the increasing opportunities associated with minimally invasive procedures are attracting international investments in the region. The presence of key players and the developing startup landscape are also driving the regional market growth.

Key Companies & Market Share Insights

The market is highly competitive due to the rising demand for disposable bronchoscopes for diagnosing and treating several lung disorders. Advancements in the market and constant product approvals from regulatory authorities are driving the growth. Some of the key players in the global disposable bronchoscopes market include:

• Olympus Corporation

• AMBU A/S

• Boston Scientific Corporation

• Smith & Nephew Inc.

• NeoScope Inc.

• Pentax Medical

• Karl Storz SE & Co.

• Fujifilm Corporation

Disposable Bronchoscope Market Report Scope

Global Disposable Bronchoscope Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest trends in each of the sub-segments from 2016 to 2030. For this study, Grand View Research, Inc. has segmented the global disposable bronchoscope market report on the basis of end-use, and region:

• End-use Outlook (Revenue, USD Million, 2016 - 2030)

  • Hospitals

  • Outpatient Facilities

• Regional Outlook (Revenue, USD Million, 2016 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • Italy

    • France

    • Spain

    • Norway

    • Sweden

    • Denmark

  • Asia-Pacific

    • Australia

    • China

    • Japan

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Mexico

    • Brazil

    • Argentina

  • Middle East Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

    • Israel

    • Qatar